Suvorexant
A potent, CNS penetrant, orally available, dual orexin receptor antagonist with Ki of 0.55 and 0.35 nM for OX1R and OX2R, respectively; significantly and dose-dependently reduces locomotor activity and promotes sleep in rats.Sleep Disorder Launched.
Product Specifications
CAS Number
1030377-33-3
Product Name Alternative
MK-4305
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
O=C (N1CCN (C2=NC3=CC (Cl) =CC=C3O2) CC[C@H]1C) C4=CC (C) =CC=C4N5N=CC=N5
Molecular Formula
C23H23ClN6O2
Molecular Weight
450.92
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(R) - (4- (5-chlorobenzo[d]oxazol-2-yl) -7-methyl-1,4-diazepan-1-yl) (5-methyl-2- (2H-1,2,3-triazol-2-yl) phenyl) methanone
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A10087-2-APC 100 µg/Vial
Anti-P2Y6/P2RY6 Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
21436154 3x 1.0 µg DNA
GEM CRISPR All-in-one AAV vector set (with saCas9)(Mouse)
Sign In for Pricing
View Details 
MBS1408341-01 0.5 mg (E-Coli)
Recombinant Shigella boydii serotype 4 Protein mgrB (mgrB), partial
Sign In for Pricing
View Details MBS1408341-02 0.05 mg (Baculovirus)
Recombinant Shigella boydii serotype 4 Protein mgrB (mgrB), partial
Sign In for Pricing
View Details MBS1408341-03 0.5 mg (Yeast)
Recombinant Shigella boydii serotype 4 Protein mgrB (mgrB), partial
Sign In for Pricing
View Details MBS1408341-04 0.05 mg (Mammalian-Cell)
Recombinant Shigella boydii serotype 4 Protein mgrB (mgrB), partial
Sign In for Pricing
View Details